Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Nicholas Moore

Showing results (281-290 of 354) with videos related to

Pageof 36
Sort By:
Pharmacoepidemiology and Drug Safety|November 21, 2012
Choice of the denominator in case population studies: event rates for registration for liver transplantation after exposure to NSAIDs in the SALT study in FranceNicholas Moore, Sinem Ezgi Gulmez, Dominique Larrey, et al.
European Journal of Paediatric Neurology : EJPN : Official Journal of the European Paediatric Neurology Society|September 17, 2013
Continuation rates of levetiracetam in children from the EULEVp cohort studyCaroline Dureau-Pournin, Jean-Michel Pédespan, Cécile Droz-Perroteau, et al.
Emergency Medicine Australasia : EMA|April 1, 2024
Trends in reported GHB-related presentations to Sydney emergency departments between 2012 and 2021Oliver Harris, Krista J Siefried, Angela Chiew, et al.
British Journal of Clinical Pharmacology|December 15, 2010
The EULEV cohort study: rates of and factors associated with continuation of levetiracetam after 1 yearCécile Droz-Perroteau, Caroline Dureau-Pournin, Hervé Vespignani, et al.
Fundamental & Clinical Pharmacology|July 29, 2011
Chemotherapy and targeted agents for colorectal cancer in a real-life setting anticipate guidelines: the COLCHIC cohort studyDenis Smith, Eric Terrebonne, Magali Rouyer, et al.
Emergency Medicine Australasia : EMA|March 9, 2026
The Sydney Triage to Admission Risk Tool With Artificial Intelligence (START-AI): Prediction of Inpatient Admission From Emergency Departments Using Ensemble Machine LearningMichael Dinh, Elizabeth Corbett, Eliot Salmon, et al.
Pharmacological Research|December 25, 2018
Comparative effectiveness of direct oral anticoagulants versus low-molecular weight heparins for the prevention of venous thromboembolism after total hip or knee replacement: A nationwide database cohort studyPatrick Blin, Charles-Marc Samama, Alain Sautet, et al.
European Journal of Clinical Pharmacology|July 28, 2011
Fluindione and drug reaction with eosinophilia and systemic symptoms: an unrecognised adverse effect?Amélie Daveluy, Brigitte Milpied, Annick Barbaud, et al.
Drug Safety|May 10, 2019
Bismuth Concentrations in Patients Treated in Real-Life Practice with a Bismuth Subcitrate-Metronidazole-Tetracycline Preparation: The SAPHARY StudyEstelle Guiard, Bénédicte Lelievre, Magali Rouyer, et al.
Journal of Geriatric Oncology|April 18, 2016
Effectiveness and safety of first-line bevacizumab plus FOLFIRI in elderly patients with metastatic colorectal cancer: Results of the ETNA observational cohortMagali Rouyer, Annie Fourrier-Réglat, Denis Smith, et al.
Pageof 36

Showing results (281-290 of 354) with videos related to

Sort By:
Pageof 36
Pharmacoepidemiology and Drug Safety|November 21, 2012
Choice of the denominator in case population studies: event rates for registration for liver transplantation after exposure to NSAIDs in the SALT study in FranceNicholas Moore, Sinem Ezgi Gulmez, Dominique Larrey, et al.
European Journal of Paediatric Neurology : EJPN : Official Journal of the European Paediatric Neurology Society|September 17, 2013
Continuation rates of levetiracetam in children from the EULEVp cohort studyCaroline Dureau-Pournin, Jean-Michel Pédespan, Cécile Droz-Perroteau, et al.
Emergency Medicine Australasia : EMA|April 1, 2024
Trends in reported GHB-related presentations to Sydney emergency departments between 2012 and 2021Oliver Harris, Krista J Siefried, Angela Chiew, et al.
British Journal of Clinical Pharmacology|December 15, 2010
The EULEV cohort study: rates of and factors associated with continuation of levetiracetam after 1 yearCécile Droz-Perroteau, Caroline Dureau-Pournin, Hervé Vespignani, et al.
Fundamental & Clinical Pharmacology|July 29, 2011
Chemotherapy and targeted agents for colorectal cancer in a real-life setting anticipate guidelines: the COLCHIC cohort studyDenis Smith, Eric Terrebonne, Magali Rouyer, et al.
Emergency Medicine Australasia : EMA|March 9, 2026
The Sydney Triage to Admission Risk Tool With Artificial Intelligence (START-AI): Prediction of Inpatient Admission From Emergency Departments Using Ensemble Machine LearningMichael Dinh, Elizabeth Corbett, Eliot Salmon, et al.
Pharmacological Research|December 25, 2018
Comparative effectiveness of direct oral anticoagulants versus low-molecular weight heparins for the prevention of venous thromboembolism after total hip or knee replacement: A nationwide database cohort studyPatrick Blin, Charles-Marc Samama, Alain Sautet, et al.
European Journal of Clinical Pharmacology|July 28, 2011
Fluindione and drug reaction with eosinophilia and systemic symptoms: an unrecognised adverse effect?Amélie Daveluy, Brigitte Milpied, Annick Barbaud, et al.
Drug Safety|May 10, 2019
Bismuth Concentrations in Patients Treated in Real-Life Practice with a Bismuth Subcitrate-Metronidazole-Tetracycline Preparation: The SAPHARY StudyEstelle Guiard, Bénédicte Lelievre, Magali Rouyer, et al.
Journal of Geriatric Oncology|April 18, 2016
Effectiveness and safety of first-line bevacizumab plus FOLFIRI in elderly patients with metastatic colorectal cancer: Results of the ETNA observational cohortMagali Rouyer, Annie Fourrier-Réglat, Denis Smith, et al.
Pageof 36